AJG vs AMRX · P/E 33, rev $8.76B vs P/E 44, rev $1.52B
Arthur J Gallagher & Co (AJG) versus Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — a side-by-side from cached financials, not a winner call.
Arthur J Gallagher & Co (AJG) is a insurance brokers company listed on US.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AJG revenue for 2026-06-30 was $8.76B. Net income was $1.15B. Revenue was up 84.1% from 2026-03-31 to 2026-06-30. AJG currently screens at market cap $52.03B and trailing P/E 32.8.
Latest reported AMRX revenue for 2026-06-30 was $1.52B. Net income was $119.9M. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
AJG currently screens at market cap $52.03B and trailing P/E 32.8. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Not investment advice. Open the AJG and AMRX stock pages for the full models.
Not investment advice.